Apta Biosciences

Developer of a synthetic biology technology platform for diagnostics and therapeutics

placeLondon, England, United Kingdom calendar_todayFounded 2013 groups11 employees language aptabiosciences.com

Registered entities

Innovation

5 patent families (5 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 101 times.

YearFilings
20142
20151
20163
20171
20191
20201
20211

Investor mix

45 investors on record; lead investors include Ranworth Capital, Danish Business Angels.

Investor typeCountShare
Venture capital37%
Private equity716%
Angel & family office12%
Other / undisclosed3476%
Coming soon